Right Remedies Stomach Relief Bismuth Subsalicylate 262 Mg Softgel Capsule, Liquid Filled
NDC Package 70692-829-84
Package Information
Right Remedies Stomach Relief Bismuth Subsalicylate 262 Mg Softgel (bismuth subsalicylate) capsules is • swallow with water, do not chew• adults and children 12 years and over: • 2 softgels every 1/2 hour or 4 softgels every hour as needed for diarrhea • 2 softgels every 1/2 hour to 1 hour as needed for overindulgence (upset stomach, heartburn, indigestion, nausea)• do not exceed 16 softgels in 24 hours• use until diarrhea stops but no more than 2 days• children under 12 years: ask a doctor• drink plenty of clear fluids to help prevent dehydration caused by diarrhea. This formulation utilizes a capsule, liquid filled delivery system. Marketed by Strive Pharmaceuticals Inc., this product is identified by NDC 70692-829 and is authorized under FDA application M008.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 70692 - Strive Pharmaceuticals Inc.
- 70692-829 - Right Remedies Stomach Relief Bismuth Subsalicylate 262 Mg Softgel
- 70692-829-84 - 48 CAPSULE, LIQUID FILLED in 1 BOTTLE
- 70692-829 - Right Remedies Stomach Relief Bismuth Subsalicylate 262 Mg Softgel
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70692-829-84 identifies a specific commercial package of 48 capsule, liquid filled in 1 bottle of Right Remedies Stomach Relief Bismuth Subsalicylate 262 Mg Softgel, a human over the counter drug labeled by Strive Pharmaceuticals Inc.. This capsule, liquid filled is formulated for oral use and contains bismuth subsalicylate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Strive Pharmaceuticals Inc. on September 23, 2025. The current certification is valid through December 31, 2026.
How is this Strive Pharmaceuticals Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70692082984. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.